Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 22, 2012

EBIXA – New Once-Daily dosing

Bookmark and Share

Lundbeck (Ireland) Ltd wish to announce that they received approval from the European Medicines Agency (EMEA) for a new Once-Daily dosing of their NMDA receptor antagonist Ebixa (memantine) for the treatment of moderate to severe Alzheimer’s disease. The approval is based on the positive findings of a clinical study that evaluated the new Ebixa 20 [...]

Change of product name from Laxoberal Liquid to Dulcolax Liquid

Bookmark and Share

Boehringer Ingelheim wishes to inform you that Laxoberal oral solution is changing name from Laxoberal Liquid 5mg/ml to Dulcolax Liquid in Ireland. There is no change in product composition.

Change of formulation for Rebif

Bookmark and Share

Merck Serono wishes to announce that Rebif New Formulation (interferon beta-1a) is now available in Ireland. In a recent 96 week Phase IIIb study, 260 patients with relapsing remitting multiple sclerosis treated with the new formulation experienced a near three-fold reduction in injection-site reactions. Patients also experienced a similar reduction in depression and suicidal ideation. [...]

Debossing of Zoton FasTab

Bookmark and Share

Wyeth Pharmaceuticals Ltd. would like to inform you of the debossing of Zoton FasTab 15mg oro-dispersible tablets and Zoton FasTab 30mg orodispersible tablets. Zoton FasTab 15mg oro-dispersible tablets will be debossed with 15 on one side; Zoton FasTab 30mg oro-dispersible tablets will be debossed with 30 on one side. The outer carton of the product [...]

Discontinuations in the Depixol and Clopixol ranges from the Irish market

Bookmark and Share

Lundbeck (Ireland) Ltd has announced the discontinuation from the Irish market of some presentations in the Depixol/Clopixol product ranges. The presentations to be discontinued are: Depixol Conc. 100mg/ml, solution for injection (10 x 0.5ml ampoules), Depixol 40mg/2ml, solution for injection (10 x 2ml ampoules), Clopixol Acuphase 100mg/2ml, solution for injection (5 x 2ml ampoules), Clopixol [...]

Discontinuation of Metocyl 10mg Tablets

Bookmark and Share

Rowa Pharmaceuticals Ltd would like to announce their intention to discontinue Metocyl 10mg Tablets 20’s & 100’s once existing stock is depleted. The expiry date of the last batch is: 10-2010. Further information is available from Rowa Pharmaceuticals Ltd. Free phone: 1800 304400. Telephone: (027) 50077. Fax: (027) 50417. E-mail: rowex@rowa-pharma.ie

Discontinuation of Prozac Weekly Caps

Bookmark and Share

Eli Lilly wish to announce the withdrawal from the market of Prozac Weekly Caps once existing stocks have been depleted. Prozac 20mg Caps, and Prozac liquid will continue to remain available. If you require any further information please contact Eli Lilly on (01) 6614377.

Discontinuation of Rocephin 2g from the Irish market

Bookmark and Share

Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Rocephin 2g powder for solution for injection or infusion. Due to low demand for the Rocephin 2g presentation, marketing of the product will cease permanently on 24th July and stock remaining in circulation should be employed until exhausted. If [...]

Discontinuation of Zineryt 90ml Pack

Bookmark and Share

Astellas Pharma Co. Ltd would like to inform you that Zineryt 90ml pack size is being discontinued. This change will come into effect once the current stocks of Zineryt 90ml have been depleted. Zineryt 30ml pack remains on the market. Should you have any queries, please do not hesitate to contact Astellas Pharma Co. Ltd [...]

« Previous Page